Nasdaq
CLYM
Climb Bio, Inc.
- Health Care
- Listed 2021
- 1 day
- +12.3%
- 1 month
- +4.3%
- 1 year
- +700%
$14.00 · Mkt cap $802M
At the 6 Aug 2026 close
Nasdaq
Climb Bio, Inc.
$14.00 · Mkt cap $802M
At the 6 Aug 2026 close
Climb Bio, Inc. trades under the ticker CLYM on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2021. Its market capitalisation is $802M. The last closing price was $14.00, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +700%, and +4.3% over the past month. Returns are price returns and exclude dividends.
This page exists because CLYM is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.